{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:34:08Z","timestamp":1782902048236,"version":"3.54.5"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T00:00:00Z","timestamp":1145491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urol Res"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1007\/s00240-006-0052-6","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T09:22:06Z","timestamp":1145438526000},"page":"288-289","source":"Crossref","is-referenced-by-count":25,"title":["Efavirenz-induced urolithiasis"],"prefix":"10.1007","volume":"34","author":[{"given":"G. J.","family":"Wirth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Teuscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"Iselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,4,20]]},"reference":[{"key":"52_CR1","unstructured":"Committee for Proprietary Medicinal Products of the European Agency for the Evaluation of Medicinal Products: European Public Assessment Report (EPAR) on Stocrin\/Efavirenz. http:\/\/www.emea.eu.int\/humandocs\/Humans\/EPAR\/Stocrin\/StocrinM.htm"},{"key":"52_CR2","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJM199912163412501","volume":"341","author":"S Staszewski","year":"1999","unstructured":"Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, et al (1999) Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med 341:1865","journal-title":"N Engl J Med"},{"key":"52_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00003495-200464030-00003","volume":"64","author":"M Daudon","year":"2004","unstructured":"Daudon M, Jungers P (2004) Drug-induced renal calculi: epidemiology, prevention and management. Drugs 64:245","journal-title":"Drugs"}],"container-title":["Urological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-006-0052-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00240-006-0052-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-006-0052-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T13:53:54Z","timestamp":1558706034000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00240-006-0052-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,20]]},"references-count":3,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1007\/s00240-006-0052-6","relation":{},"ISSN":["0300-5623","1434-0879"],"issn-type":[{"value":"0300-5623","type":"print"},{"value":"1434-0879","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,20]]}}}